Huang XiaoJian

Dr. Huang XiaoJian

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
BNBowei Ni
Bowei Ni
WPWenbin Pei
Wenbin Pei
YQYunkun Qu
Yunkun Qu
RZRui Zhang
Rui Zhang
XCXiangyu Chu
Xiangyu Chu
HYHongBo You
HongBo You
Osteoarthritis (OA), characterized by chronic systemic low‐level inflammation and cartilage degeneration, is a type of arthritis closely associated with aging. Inflammation and aging play a pivotal role in the occurrence and progression of OA. NLRP3 inflammasome is involved in many inflammatory and aging diseases, and NLRP3 inhibitor MCC950 has anti‐inflammatory and antisenescence effects on some diseases such as Alzheimer’s disease. In the present study, we found that NLRP3 protein was upregulated in human and mouse OA cartilage. Moreover, NLRP3 and Caspase1 expression induced by IL‐1β in chondrocytes was blocked by MCC950. In addition, MCC950 inhibited the expression of inflammatory mediators, matrix‐degrading enzymes, senescence marker protein P16 (INK4A), and β‐galactosidase, as well as excessive production of ROS. Meanwhile, MCC950 promoted autophagy‐related protein expression and autophagy flux under the inflammatory condition. However, autophagy inhibitor 3‐MA reversed anti‐inflammatory and anticatabolic effects of MCC950. In in vivo experiments, intra‐articular administration of MCC950 further showed its protective effect on cartilage degeneration. Bioinformatic analysis and in vitro experimental results revealed that MCC950 might play a protective role in cartilage by regulating Nrf2/HO‐1/NQO1, PI3k/Akt/mTOR, P38/MAPK, and JNK/MAPK pathways. In conclusion, our work demonstrated that NLRP3 inhibitor MCC950 might serve as a promising strategy for OA treatment.

25 April 2023 in Computers in Biology and Medicine
Verified
Journal Article
Open access
YQYunkun Qu
Yunkun Qu
YWYingguang Wang
Yingguang Wang
SWShanxi Wang
Shanxi Wang
XYXiaojun Yu
Xiaojun Yu
YHYi He
Yi He
HYHongBo You
HongBo You
Osteoarthritis (OA) has become the most common degenerative disease in the world, which brings a serious economic burden to society and the country. Although epidemiological studies have shown that the occurrence of osteoarthritis is associated with obesity, sex, and trauma, the biomolecular mechanisms for the development and progression of osteoarthritis remain ambiguous. Several studies have drawn a connection between SPP1 and osteoarthritis. SPP1 was first found to be highly expressed in osteoarthritic cartilage, and later more studies have shown that SPP1 is also highly expressed in subchondral bone and synovial in OA patients. However, the biological function of SPP1 remains unclear. Single-cell RNA sequencing (scRNA-seq) is a novel technique that reflects gene expression at the cellular level, making it better depict the state of different cells than ordinary transcriptome data. However, most of the existing chondrocyte scRNA-seq studies focus on the occurrence and development of OA chondrocytes and lack analysis of normal chondrocyte development. Therefore, to better understand the mechanism of OA, scRNA-seq analysis of a larger cell volume containing normal and osteoarthritic cartilage is of great importance. Our study identifies a unique cluster of chondrocytes characterized by high SPP1 expression. The metabolic and biological characteristics of these clusters were further investigated. Besides, in animal models, we found that the expression of SPP1 is spatially heterogeneous in cartilage. Overall, our work provides novel insight into the potential role of SPP1 in OA, which sheds light on understanding the role of SPP1 in OA, promoting the progress of the treatment and prevention in the field of OA.

1 November 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
HXHuang XiaoJian
Huang XiaoJian
XYXi Yang
Xi Yang
QPQiyong Pan
Qiyong Pan
ZMZekai Mao
Zekai Mao
RZRui Zhang
Rui Zhang
HYHongBo You
HongBo You

30 July 2022 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
YZYingchi Zhang
Yingchi Zhang
RLRui Lu
Rui Lu
HXHuang XiaoJian
Huang XiaoJian
EYEnzhi Yin
Enzhi Yin
YYYong Yang
Yong Yang
XYXuefeng Yuan
Xuefeng Yuan
Osteoarthritis (OA) is a rheumatic disease and its pathogenesis involves the dysregulation of noncoding RNAs. Therefore, the regulatory mechanism of circular RNA MELK (circMELK) was specified in this work. OA human cartilage tissue was collected, and circMELK, miR‐497‐5p, and myeloid differentiation factor 88 (MYD88) expression were examined. Human chondrocytes were stimulated with interleukin‐ (IL‐) 1β and interfered with vectors altering circMELK, miR‐497‐5p, and MyD88 expression to observe their effects on cell viability, cell cycle and apoptosis, autophagy, and inflammation. The binding relationship between RNAs was verified. The data presented that OA cartilage tissues presented raised circMELK and MYD88 and inhibited miR‐497‐5p expression. IL‐1β suppressed cell viability, prevented cell cycle, and induced apoptosis, autophagy, and inflammation of chondrocytes. Functionally, IL‐1β‐induced changes of chondrocytes could be attenuated by suppressing circMELK or overexpressing miR‐497‐5p. circMELK acted as a sponge of miR‐497‐5p while miR‐497‐5p was a regulator of MYD88. MYD88 restricted the effect of overexpressing miR‐497‐5p on IL‐1β‐stimulated chondrocytes. MYD88 triggered nuclear factor‐kappaB (NF‐κB) pathway activation. Shortly, CircMELK promotes chondrocyte apoptosis and inhibits autophagy in OA by regulating MYD88/NF‐κB signaling axis through miR‐497‐5p. Our study proposes a new molecular mechanism for the development of OA.


2 August 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
SCSheng Chen
Sheng Chen
CMChen Meng
Chen Meng
YHYi He
Yi He
HXHanqing Xu
Hanqing Xu
YQYunkun Qu
Yunkun Qu
HYHongBo You
HongBo You